Trademark/Service Mark Application, Principal Register
PTO- 1478
Approved for use through 10/31/2024. OMB 0651-0009
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number
Trademark/Service Mark Application, Principal Register
Research and development in the pharmaceutical field; consulting services in the field of pharmaceutical research and development; scientific
research and development; scientific investigations for medical purposes; providing medical and scientific research information in the field of pharmaceuticals and clinical trials
FILING BASIS
SECTION 1(b)
ATTORNEY INFORMATION
NAME
Glenn A. Gundersen
ATTORNEY BAR MEMBERSHIP NUMBER
XXX
YEAR OF ADMISSION
XXXX
U.S. STATE/ COMMONWEALTH/ TERRITORY
XX
FIRM NAME
Dechert LLP
INTERNAL ADDRESS
Cira Centre
STREET
2929 Arch Street
CITY
Philadelphia
STATE
Pennsylvania
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY
United States
ZIP/POSTAL CODE
19104
EMAIL ADDRESS
trademarks@dechert.com
CORRESPONDENCE INFORMATION
NAME
Glenn A. Gundersen
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE
trademarks@dechert.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES)
NOT PROVIDED
FEE INFORMATION
APPLICATION FILING OPTION
TEAS Standard
NUMBER OF CLASSES
2
APPLICATION FOR REGISTRATION PER CLASS
350
*TOTAL FEES DUE
700
*TOTAL FEES PAID
700
SIGNATURE INFORMATION
SIGNATURE
/Mina Sooch/
SIGNATORY'S NAME
Mina Sooch
SIGNATORY'S POSITION
President and CEO
SIGNATORY'S PHONE NUMBER
12489806538
DATE SIGNED
10/10/2022
SIGNATURE METHOD
Sent to third party for signature
PTO- 1478
Approved for use through 10/31/2024. OMB 0651-0009
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number
Trademark/Service Mark Application, Principal Register
Serial Number:97626126
Filing Date:10/10/2022
To the Commissioner for Trademarks:
MARK: RYZUMVI (Standard Characters, see mark)
The literal element of the mark consists of RYZUMVI. The mark consists of standard characters, without claim to any particular font style, size, or color.
The applicant, OCUPHIRE PHARMA, INC., a corporation of Delaware, having an address of
37000 Grand River Avenue, Suite 120
Farmington Hills, Michigan 48335
United States
XXXX
requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C.
Section 1051 et seq.), as amended, for the following:
International Class 005: Pharmaceutical preparations; veterinary preparations
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.
International Class 042: Research and development in the pharmaceutical field; consulting services in the field of pharmaceutical research and development; scientific research and development;
scientific investigations for medical purposes; providing medical and scientific research information in the field of pharmaceuticals and clinical trials
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.
The owner's/holder's proposed attorney information: Glenn A. Gundersen. Glenn A. Gundersen of Dechert LLP, is a member of the XX bar, admitted to the bar in XXXX, bar membership no. XXX, is
located at
Cira Centre
2929 Arch Street
Philadelphia, Pennsylvania 19104
United States
trademarks@dechert.com
Glenn A. Gundersen submitted the following statement: The attorney of record is an active member in good standing of the bar of the highest court of a U.S. state, the District of Columbia, or any
U.S. Commonwealth or territory.
The applicant's current Correspondence Information:
Glenn A. Gundersen
PRIMARY EMAIL FOR CORRESPONDENCE: trademarks@dechert.com SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): NOT PROVIDED
Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed,
and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).
A fee payment in the amount of $700 has been submitted with the application, representing payment for 2 class(es).
Declaration
Declaration Signature
Signature: /Mina Sooch/ Date: 10/10/2022
Signatory's Name: Mina Sooch
Signatory's Position: President and CEO
Signatory's Phone Number: 12489806538
Signature method: Sent to third party for signature
Payment Sale Number: 97626126
Payment Accounting Date: 10/11/2022
Serial Number: 97626126
Internet Transmission Date: Mon Oct 10 17:35:15 ET 2022
TEAS Stamp: USPTO/BAS-XXX.XXX.XXX.X-2022101017351575
2672-97626126-820cd1a604dea4922b1bebeec8
ba102b3e759f3b742a4b79a818652533e3e3db4-
DA-35151901-20221010165239013791